Cytokine complex-expanded natural killer cells improve allogeneic lung transplant function via depletion of donor dendritic cells

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 12, 2013, Pages 1349-1359

  Jungraithmayr, Wolfgang ^a,b   Codarri, Laura ^a   Bouchaud, Gregory ^c   Krieg, Carsten ^c   Boyman, Onur ^c   Gyülvészi, Gabor ^a   Becher, Burkhard ^a   Weder, Walter ^b   Münz, Christian ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Acute rejection; Dendritic cells; Lung; Mouse transplantation; Natural killer cells

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; PERFORIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOREGULATION; IN VITRO STUDY; LEUKOCYTE MIGRATION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ANIMALS; DENDRITIC CELLS; GRAFT REJECTION; INTERLEUKIN-15; KILLER CELLS, NATURAL; LUNG TRANSPLANTATION; MICE; RECEPTORS, INTERLEUKIN-15;

EID: 84879569320     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201209-1749OC     Document Type: Article

References (45)

1. Hardy JD, Webb WR, Dalton ML Jr, Walker GR Jr. Lung homotransplantation in man. JAMA 1963;186: 1065-1074.
2. Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report - 2010. J Heart Lung Transplant 2010;29: 1104-1118.
3. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science 2011;331: 44-49.
4. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002;2: 957-964.
5. Shi FD, Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev Immunol 2006;6: 751-760.
6. Chijioke O, Münz C. Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo. J Biomed Biotechnol 2011;2011: 251679.
7. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005;5: 112-124.
8. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting NK cells and are recognized via the NKp30 receptor by activated NK cells. J ExpMed 2002;195: 343-351.
9. Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195: 335-341.
10. Hayakawa Y, Screpanti V, Yagita H, Grandien A, Ljunggren HG, Smyth MJ, Chambers BJ. NK cell trail eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 2004; 172: 123-129.
11. Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R. Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Ra-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 2006;103: 5941-5946.
12. Waggoner SN, Cornberg M, Selin LK, Welsh RM. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012;481: 394-398.
13. Rabinovich BA, Li J, Shannon J, Hurren R, Chalupny J, Cosman D, Miller RG. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J Immunol 2003;170: 3572-3576.
14. Lu L, Ikizawa K, Hu D, Werneck MB, Wucherpfennig KW, Cantor H. Regulation of activated CD41 T cells by NK cells via the Qa-1- NKG2A inhibitory pathway. Immunity 2007;26: 593-604.
15. Lanier LL. NK cell recognition. Annu Rev Immunol 2005;23: 225-274.
16. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001;19: 197-223.
17. Strowig T, Brilot F, Münz C. Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J Immunol 2008;180: 7785-7791.
18. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, LippM, Lanzavecchia A, Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-g for TH1 priming. Nat Immunol 2004;5: 1260-1265.
19. Bajenoff M, Breart B, Huang AY, Qi H, Cazareth J, Braud VM, Germain RN, Glaichenhaus N. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J ExpMed 2006;203: 619-631.
20. Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. Transforming growth factor-b controls T helper type 1 cell development through regulation of natural killer cell interferon-g. Nat Immunol 2005;6: 600-607.
21. Morandi B, Bougras G, Muller WA, Ferlazzo G, Münz C. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-g secretion. Eur J Immunol 2006;36: 2394-2400.
22. Jungraithmayr W, Weder W. The technique of orthotopic mouse lung transplantation as a movie-improved learning by visualization. Am J Transplant 2012;12: 1624-1626.
23. Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, Surh CD, Sprent J. Converting IL-15 to a superagonist by binding to soluble IL- 15Ra. Proc Natl Acad Sci USA 2006;103: 9166-9171.
24. Jungraithmayr W, Chuck N, Frauenfelder T, Weder W, Boss A. MR imaging by using very short echo time sequences after syngeneic lung transplantation in mice. Radiology 2012;265: 753-761.
25. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26: 1229-1242.
26. Hayakawa Y, SmythMJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006; 176: 1517-1524.
27. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, Matsuki N, Charrier K, Sedger L, Willis CR, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15- deficient mice. J Exp Med 2000;191: 771-780.
28. Koka R, Burkett PR, Chien M, Chai S, Chan F, Lodolce JP, Boone DL, Ma A. Interleukin (IL)-15Ra-deficient natural killer cells survive in normal but not IL-15Ra-deficient mice. J Exp Med 2003;197: 977-984.
29. Burkett PR, Koka R, Chien M, Chai S, Chan F, Ma A, Boone DL. IL- 15Ra expression on CD81 T cells is dispensable for T cell memory. Proc Natl Acad Sci USA 2003;100: 4724-4729.
30. Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008;112: 661-671.
31. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. Sensitive and viable identification of antigen-specific CD81 T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281: 65-78.
32. Maier S, Tertilt C, Chambron N, Gerauer K, Huser N, Heidecke CD, Pfeffer K. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD282/2 mice. Nat Med 2001;7: 557-562.
33. McNerney ME, Lee KM, Zhou P, Molinero L, Mashayekhi M, Guzior D, Sattar H, Kuppireddi S, Wang CR, Kumar V, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006; 6: 505-513.
34. Uehara S, Chase CM, Kitchens WH, Rose HS, Colvin RB, Russell PS,Madsen JC. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005;175: 3424-3430.
35. Beilke JN, Kuhl NR, Van Kaer L, Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005;11: 1059-1065.
36. Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006;203: 1851-1858.
37. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, Posati S, Rogaia D, Frassoni F, Aversa F, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295: 2097-2100.
38. Hsu KC, Keever-Taylor CA, Wilton A, Pinto C, Heller G, Arkun K, O'Reilly RJ, Horowitz MM, Dupont B. Improved outcome in HLAidentical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 2005;105: 4878-4884.
39. Leung W, Iyengar R, Turner V, Lang P, Bader P, Conn P, Niethammer D, Handgretinger R. Determinants of antileukemia effects of allogeneic NK cells. J Immunol 2004;172: 644-650.
40. Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood 2005;105: 3051-3057.
41. Ferlazzo G, Thomas D, Pack M, Paludan C, Schmid D, Strowig T, Muller WA, Moretta L, Münz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004;101: 16606-16611.
42. Koka R, Burkett P, Chien M, Chai S, Boone DL, Ma A. Cutting edge: murine dendritic cells require IL-15Ra to prime NK cells. J Immunol 2004;173: 3594-3598.
43. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007;26: 503-517.
44. Huntington ND, Alves NL, Legrand N, Lim A, Strick-Marchand H, Mention JJ, Plet A, Weijer K, Jacques Y, Becker PD, et al. IL-15 transpresentation promotes both human T-cell reconstitution and Tcell- dependent antibody responses in vivo. Proc Natl Acad Sci USA 2011;108: 6217-6222.
45. Zecher D, Li Q, Oberbarnscheidt MH, Demetris AJ, Shlomchik WD, Rothstein DM, Lakkis FG. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD81 T cells. J Immunol 2010;184: 6649-6657.